Tuesday, 22 January 2019
Latest news
Main » CVS Health (NYSE:CVS) Position Trimmed by Haverford Financial Services Inc

CVS Health (NYSE:CVS) Position Trimmed by Haverford Financial Services Inc

17 May 2018

Hedge funds and other institutional investors own 83.96% of the company's stock. They expect $-0.11 EPS, up 31.25 % or $0.05 from last year's $-0.16 per share. (NASDAQ:CAPR) for 1.14M shares. On Wednesday, May 2 the stock of CVS Health Corporation (NYSE:CVS) earned "Buy" rating by Oppenheimer. CVS underperformed by 34.36% the S&P500.

First Western Capital Management Company decreased its stake in Us Bancorp Del Com New (USB) by 51.22% based on its latest 2017Q4 regulatory filing with the SEC. The fund owned 90,080 shares of the pharmacy operator's stock after selling 13,447 shares during the period. The stock decreased 0.25% or $0.13 during the last trading session, reaching $50.99. About 5.49M shares traded. That represents a quarterly year/year change in revenues of 0.03 in sequential terms, the CVS saw sales decline by -0.06. It has underperformed by 5.12% the S&P500. Bank of America decreased their target price on shares of CVS Health from $91.00 to $88.00 and set a "buy" rating for the company in a research note on Wednesday, April 11th. CVS Health has a 1-year low of $66.05 and a 1-year high of $66.81. The stock has a market capitalization of $65.48 billion, a P/E ratio of 11.16, a PEG ratio of 0.96 and a beta of 1.02. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.09. At present, 2 analysts recommended Holding these shares while 1 recommended sell, according to FactSet data. It also increased its holding in Allergan Plc by 560 shares in the quarter, for a total of 2,132 shares, and has risen its stake in Mueller Wtr Prods Inc (NYSE:MWA). Mizuho set a $95.00 target price on CVS Health and gave the company a "buy" rating in a research note on Wednesday, January 24th. Therefore 73% are positive. Loop Capital set a $68.00 price target on shares of CVS Health and gave the stock a "hold" rating in a report on Monday, May 7th. Citigroup has "Neutral" rating and $77 target.

Price targets show what analysts believes a stock will be worth at the end of a certain time period. The rating was downgraded by Morgan Stanley to "Equal-Weight" on Monday, June 20. The firm has "Buy" rating by Tigress Financial given on Friday, April 28. On Tuesday, November 21 the rating was maintained by Leerink Swann with "Buy". Three research analysts have rated the stock with a sell rating, six have issued a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the stock. Rech Global has 0.1% invested in CVS Health Corporation (NYSE:CVS).

Since February 16, 2018, it had 2 insider purchases, and 1 insider sale for $713,454 activity. Roffman Miller Inc Pa invested in 1.28% or 142,641 shs. Its down 0.16, from 0.88 in 2017Q3. 134 funds opened positions while 380 raised stakes. The insider DORMAN DAVID W bought $1.51 million. 10 has 23,039 shares. Funds own 815.59 million shares, up from 801.45 million shares in 2017Q3. Carlton Hofferkamp And Jenks Wealth holds 0.62% or 13,708 shares in its portfolio. (NASDAQ:CAPR). Geode Cap Management Limited Com reported 0% in Capricor Therapeutics, Inc. CVS Health's dividend payout ratio is now 33.90%. Vigilant Cap Lc holds 0.54% or 56,338 shs. Drw Limited Liability Corp holds 14,208 shares. Moreover, Pitcairn has 0.08% invested in CVS Health Corporation (NYSE:CVS). Savings Bank Of The Ozarks accumulated 16,471 shares. Paradigm Asset Mngmt Limited Company owns 0.11% invested in CVS Health Corporation (NYSE:CVS) for 5,470 shares. Butensky And Cohen Fincl Security holds 1.5% of its capital in CVS Health Corporation (NYSE:CVS) for 25,042 shs. Coastline Trust Co holds 0.32% or 29,094 shares in its portfolio.

Sawtooth Solutions LLC lifted its stake in CVS Health (NYSE:CVS) by 12.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The titles are as follows: "Trade Mistake 3: CVS Boredom Trade" brought out on May 09, 2018, "CVS Health: A Store-Level Look At The Proposed Healthcare Giant" on April 26, 2018, "Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more...) -13F" with a publish date: May 15, 2018, "Moody's likes the upward financial trend at this Lakeland pharmacy benefits manager" and the last "We Are Playing The CVS Hand" with publication date: May 11, 2018.

More news for U.S. Bancorp (NYSE:USB) were recently published by: 247Wallst.com, which released: "US Bancorp May Have a Serious Valuation Issue" on April 19, 2018. Cibc Asset Mgmt reported 0.04% in CVS Health Corporation (NYSE:CVS). For shareholders, given the total diluted outstanding shares of 1.02 billion, this means overall earnings per share of 0.98. $1.42 million worth of stock was sold by Foulkes Helena on Friday, February 16. About 215,459 shares traded. On Monday, November 2 the stock rating was maintained by S&P Research with "Strong Buy".